Cetrosar 0.25mg Injection
Marketer
Sarabhai Chemicals Ltd
Salt Composition
Cetrorelix (0.25mg)
Overview Cetrosar 0.25mg Injection
Ganirelix 0.25mg Injection, an antagonist of gonadotropin-releasing hormone, treats female infertility. It suppresses premature egg release, preventing ovulation. Administered subcutaneously by a healthcare professional, self-injection is contraindicated. Your doctor or nurse will provide guidance on home injection technique. Dosage and frequency vary depending on individual needs and are determined by your physician to optimize treatment. Continue using this medication as prescribed. Common side effects include injection site reactions (redness, itching, and soreness), nausea, and vomiting. Rotate injection sites on the abdomen daily to minimize irritation. Seek immediate medical attention for dizziness, fainting, abdominal pain, or severe vomiting. Prior to treatment, inform your doctor of any liver or kidney conditions, breastfeeding, and all other medications you are currently taking, as interactions may affect efficacy or alter the drug's action.
Primary Ingredients of Cetrosar 0.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Cetrosar 0.25mg Injection
Inability to conceive in women
Major Benefits of Cetrosar 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cetrosar 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Cetrosar 0.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Cetrosar 0.25mg Injection works:
For women receiving infertility treatment, the premature discharge of immature eggs, unsuitable for fertilization, can occur. Cetrosar 0.25mg Injection inhibits a naturally occurring hormone, thereby preventing the ovary from prematurely releasing eggs.
SAFETY ADVICE
AlcoholCAUTION
Using Cetrosar 0.25mg Injection concurrently with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Cetrosar 0.25mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, given that research in both animal and human studies has revealed considerable harm to the fetus.
Breast feedingUNSAFE
Administering Cetrosar 0.25mg Injection while breastfeeding is contraindicated due to the potential for infant toxicity. Studies indicate a risk of harmful effects to the nursing infant.
DrivingSAFE
Administering Cetrosar 0.25mg Injection typically does not impair driving capabilities.
KidneyCAUTION
Administering Cetrosar 0.25mg Injection to individuals with impaired kidney function requires careful monitoring. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting severe kidney disease, Cetrosar 0.25mg Injection is contraindicated.
LiverCAUTION
Patients with hepatic impairment should receive Cetrosar 0.25mg Injection cautiously, potentially requiring a modified dosage. Physician consultation is recommended.
What if you forget to take Cetrosar 0.25mg Injection :
Omit a Cetrosar 0.25mg Injection dose? Seek your physician's advice.
Facts to Know About Cetrosar 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Category | Peptide chains |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
| Action Class | GnRH receptor blockers |
3,018 People bought this recently